MED : Impact Factor & More
eISSN: 2666-6340pISSN: 2666-6340
Share this on:
Key Metrics
Scite Index 
0.91 5-Year SI
SJR
Q1Medicine (miscellaneous)
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on MED
MED Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2020 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in MED ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in MED
Plasma proteomics linking primary and secondary diseases: Insights into molecular mediation from UK Biobank data.
- 4 Aug 2026
- Med (New York, N.Y.)
Gene therapy for hypertrophic cardiomyopathy: From feasibility to a fieldwide framework.
- 30 Jul 2026
- Med (New York, N.Y.)
Rewriting the sarcomere: Gene therapy approaches for hypertrophic cardiomyopathy from bench to bedside.
- 29 Jul 2026
- Med (New York, N.Y.)
Burden of 10 mental disorders in low- and middle-income countries, 1990-2023, with forecasts to 2050: a Global Burden of Disease Study.
- 29 Jul 2026
- Med (New York, N.Y.)
Immunologic Determinants of Infusion Products and the Tumor Microenvironment Govern Response to TIL Therapy in Advanced Melanoma
- 29 Jul 2026
- Med (New York, N.Y.)
Ethics of gene therapy.
- 22 Jul 2026
- Med (New York, N.Y.)
Plasma proteomics linking primary and secondary diseases: Insights into molecular mediation from UK Biobank data.
- 4 Aug 2026
- Med (New York, N.Y.)
Gene therapy for hypertrophic cardiomyopathy: From feasibility to a fieldwide framework.
- 30 Jul 2026
- Med (New York, N.Y.)
Rewriting the sarcomere: Gene therapy approaches for hypertrophic cardiomyopathy from bench to bedside.
- 29 Jul 2026
- Med (New York, N.Y.)
Burden of 10 mental disorders in low- and middle-income countries, 1990-2023, with forecasts to 2050: a Global Burden of Disease Study.
- 29 Jul 2026
- Med (New York, N.Y.)
Immunologic Determinants of Infusion Products and the Tumor Microenvironment Govern Response to TIL Therapy in Advanced Melanoma
- 29 Jul 2026
- Med (New York, N.Y.)
Ethics of gene therapy.
- 22 Jul 2026
- Med (New York, N.Y.)
FAQs on MED
How long has MED been actively publishing? 
What is the publishing frequency of MED?
How many articles did MED publish last year?
What is the eISSN & pISSN for MED?
What is the SJR for MED?
Who is the publisher of MED?
